CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 


Kymera Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



KYMR Gross Profit Margin (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter


Y / Y Revenue Change - - - - -
Seq. Revenue Change - - - - -
Revenue In Millions $18.70 $-14.53 $14.53 $0.00 $0.00
Gross Profit Margin - - - - -
Gross Profit Margin Total Ranking # 850 # # 801 # 792 # 725
Gross Profit In Millions $18.70 $-14.53 $14.53 $0.00 $0.00
Y / Y Gross Profit Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2021 Gross Profit Margin
Kymera Therapeutics Inc has managed to improve its Revenue sequentially to $19 millions by -228.69 % faster than Gross Profit increase of -228.69 % to $19 millions, this led to contraction in Gross Profit Margin to 100 %, a new company low.

Observing first quarter 2021 results within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated compare to previous quarter from to 850.
Learn about Gross Margin
KYMR's Gross Profit Margin first quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 52
Healthcare Sector # 229
Overall # 842

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Sep 30 2023)  




Other Gross Profit Margin Profitability Ratios
KYMR's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
KYMR's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for KYMR's Competitors
Gross Profit Margin Profit Margin for Kymera Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Gross Profit Growth
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2021, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginMar 31 2021 MRQ Gross ProfitMar 31 2021 MRQ Revenue
Adaptimmune Therapeutics Plc  100.00 %$ 0.859 $ 0.859 
Adverum Biotechnologies Inc   100.00 %$ 7.500 $ 7.500 
Avalon Globocare Corp   100.00 %$ 0.290 $ 0.290 
Alector Inc   100.00 %$ 4.110 $ 4.110 
Aligos Therapeutics Inc   100.00 %$ 0.910 $ 0.910 
Allogene Therapeutics inc   100.00 %$ 38.345 $ 38.345 
Armata Pharmaceuticals Inc   100.00 %$ 1.066 $ 1.066 
Atara Biotherapeutics Inc   100.00 %$ 3.552 $ 3.552 
Biocardia Inc  100.00 %$ 0.046 $ 0.046 
Beam Therapeutics Inc   100.00 %$ 0.006 $ 0.006 
C4 Therapeutics Inc   100.00 %$ 7.426 $ 7.426 
Codiak Biosciences Inc   100.00 %$ 13.191 $ 13.191 
Cidara Therapeutics Inc   100.00 %$ 2.408 $ 2.408 
Cullinan Oncology Inc   100.00 %$ 18.943 $ 18.943 
Cardiff Oncology inc   100.00 %$ 0.072 $ 0.072 
Curis Inc   100.00 %$ 2.189 $ 2.189 
Crispr Therapeutics Ag  100.00 %$ 0.539 $ 0.539 
Cyclo Therapeutics Inc   100.00 %$ 0.358 $ 0.358 
Dbv Technologies S a   100.00 %$ 2.941 $ 2.941 
Denali Therapeutics Inc   100.00 %$ 7.923 $ 7.923 
Precision Biosciences Inc  100.00 %$ 16.349 $ 16.349 
Editas Medicine Inc   100.00 %$ 6.499 $ 6.499 
Enzon Pharmaceuticals inc   100.00 %$ 0.381 $ 0.381 
Fate Therapeutics Inc   100.00 %$ 11.142 $ 11.142 
4d Molecular Therapeutics Inc   100.00 %$ 2.000 $ 2.000 
Finch Therapeutics Group Inc   100.00 %$ 3.553 $ 3.553 
Fresh Tracks Therapeutics Inc   100.00 %$ 0.017 $ 0.017 
Genocea Biosciences Inc   100.00 %$ 0.854 $ 0.854 
Gritstone Bio Inc   100.00 %$ 39.693 $ 39.693 
Immunitybio inc   100.00 %$ 0.139 $ 0.139 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com